Clinico-Pathological Correlations of the Most Common Neurodegenerative Dementias

Abstract

Neurodegenerative dementias are a group of neurological disorders characterized by deterioration in several cognitive domains in which there is selective and progressive loss of specific populations of neurons. The precise neurobiological basis for the different neurodegenerative dementias remains unknown. It is expected that different pathologies reflect different mechanisms, at least early in the neurodegeneration process. The next decades promise treatments directed to causes and mechanisms, bringing an outstanding challenge to clinicians due to heterogeneous clinical presentations with the same molecular pathology. The purpose of this brief review is to describe the key neuropathological features of the most common neurodegenerative dementias (Alzheimer disease, dementia with Lewy bodies and Parkinson’s disease dementia, and frontotemporal lobar degeneration) and the relationship with the clinical syndromes described in clinico-pathological studies. We expect this overview contributes for the understanding of this broad topic integrating the two ends of the spectrum: clinical and pathological.

A Low-Molecular-Weight Ferroxidase Is Increased in the CSF of sCJD Cases: CSF Ferroxidase and Transferrin as Diagnostic Biomarkers for sCJD

“…Intense efforts have therefore been directed at early diagnosis to enable initiation of available therapeutic strategies (33). Nevertheless, specific diagnosis is often missed or delayed until pathognomonic signs are obvious and neuronal death is irrevocable (67). An added concern is the misdiagnosis of potentially treatable DMs as sporadic Creutzfeldt-Jakob disease (sCJD), a uniformly fatal and potentially infectious DM with limited therapeutic options (10,21,29,71,72).…”

Reversible parkinsonism due to a large intracranial tumour

“…The prevalence of this disorder gradually increases after 50–60 years of age. Pathologically, it is defined by dopaminergic neuron loss in the substantia nigra and by the presence of intraneuronal Lewy bodies composed of α-synuclein 7 8. The diagnosis is achieved essentially through accurate clinical exploration and reasoning, as there are no tests which can confirm the diagnosis in vivo, apart from genetic testing in a few cases 1.…”

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines

“…Neurological diseases are largely defined by their symptoms which are believed to reflect the anatomical location of their underlying pathology. NDs are a group of medical conditions nosologically classified according to primary clinical signs and symptoms, anatomical distribution of neurodegeneration, or histopathological and molecular findings [6]. Common features include a late-onset disease, neural atrophy, synaptic dysfunction, mitochondrial dysfunction, OS, neural cell apoptosis, and impaired protein homeostasis [139].…”